Trending News
News
News
Galapagos and BioFocus Forms Biopharma Outfit
Galapagos hopes that its acquisition of BioFocus will accelerate its transition to a fully integrated drug development biopharmaceutical company.
News
DeltaNu Wins Prestigious R&D 100 Award
The product, released earlier this year by DeltaNu, is the Investigator which is used to follow high speed chemical reactions that are accelerated by microwaves.
News
Tecan at Biotechnica 2005
Visitors to the show will have opportunity to see the features on Tecan's Freedom EVO® series of automated workstations, the HS 400 Pro fully automated hybridization station, the high sensitivity LS Reloaded Scanner and the flexible Safire2 microplate reader.
News
Vion Licenses Heterocyclic Hydrazones
The hydrazones have unique chemical structures and biologic activity, and have shown potent cytotoxic activity in the National Cancer Institute's tumor cell panels and in vivo anticancer testing.
News
Renowned Neuroscientist Joins CytRx Scientific Advisory Board
Professor Burnstock, who played a major role in the development of CytRx's lead small molecule drug candidate arimoclomol, joins CytRx's Advisory Board.
News
Genzyme Expands Global Infrastructure for Manufacturing and Product Development
The expanded facilities will support Genzyme's continued growth and innovation, particularly in the areas of antibody and protein-based medicines.
News
MorphoSys Announces Cross Licensing of Technologies with Lilly
MorphoSys receives a license under the Kauffman patent estate to generate and screen certain recombinant peptide and protein libraries and to commercialize any resulting products.
News
CEM Creates New Division for Chemical Synthesis Scale Up
The Chemical Synthesis Scale-up Division will be charged with developing systems to produce multi-kilogram to manufacturing scale quantities of synthesized materials.
News
Scientists Solve Structure of Protein That Powers Cell Movement
The scientists at Boston Biomedical combined the power of several techniques including X-ray crystallography, resonance energy transfer and molecular modeling to obtain a three-dimensional, atomic resolution structure of the neck region of myosin V.
News
Agreement to Streamline Drug Development
Invitrogen will combine its Voltage Sensor Probes ion channel reagents with PerkinElmer’s CellLux™ Fluorescence Cellular Screening Platform.
Advertisement